Aimmune Nestle Health Science US R&D LLC
- Address
- 8000 Marina Boulevard Suite 300
Sponsor Overview
Specializations
Exocrine Pancreatic Insufficiency
The sponsor’s clinical research is centered on exocrine pancreatic insufficiency, with interest in therapies that support digestive enzyme replacement and improve fat and nitrogen absorption in affected adults.
- Pancreatic enzyme therapy
- Lipase-based treatment
- Nutrient absorption
Research activity in this area reflects a focus on gastrointestinal and pancreatic disorders where restoring digestive function is clinically important.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 2a Randomized Open-Label Crossover Study of Oral NHS7108 in Adults with Exocrine Pancreatic Insufficiency |  Bulgaria Hungary Italy Poland Spain | Recruiting |
Data & Insights
This sponsor works with 4 molecules, of which 2 are not being studied by other sponsors.
This sponsor has worked with 20 sites across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases1 trial211 other sponsors
Partnered Research Centres
20 centres- Address
- Via Consolare Valeria N 1, 98124 Messina
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
- Address
- Viale Azeglio Ciampi Snc, 95121 Catania
- Address
- Via Di Grottarossa 1035-1039, 00189 Rome
- Address
- Ul. Kosynierow Gdynskich 61, 93-357 Lodz
- Address
- Podmaniczky Utca 109, 1062 Budapest
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Aimmune Nestle Health Science US R&D LLC.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.